Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen informed lawmakers the company would look at new talks with insurers with regards to the list costs of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. https://kethek.com/